Cite
MLA Citation
Benjamin Garmezy et al.. “Clinical and Molecular Characterization of POLE Mutations as Predictive Biomarkers of Response to Immune Checkpoint Inhibitors in Advanced Cancers.” JCO precision oncology, vol. 6, 2022, p. . http://access.bl.uk/ark:/81055/vdc_100150611472.0x00001d